SPDR Series Trust - SPDR S&P Biotech ETF (NYSEMKT: XBI)
SPDR Series Trust - SPDR S&P Biotech ETF Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
SPDR Series Trust - SPDR S&P Biotech ETF Company Info
The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index.
News & Analysis
Biotech vs. Pharma: What's the Difference?
SPDR S&P Biotech ETF (XBI): How to Buy
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
The Federal Reserve's fight against inflation may soon yield financial benefits.
3 Top ETFs I Plan to Buy in April
These ETFs are easy, low-cost ways to invest in certain themes.
3 Thematic Growth ETFs to Load Up on Right Now
These three thematic ETFs could be potent growth vehicles in years to come.
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
2 ETFs That Can Set You Up for Life
Simplifying your investment strategy can help minimize your risk while still allowing you to earn some great returns.
3 Unstoppable ETFs to Stock Up On in 2023
These ETFs could be big winners in the new year.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.